| Literature DB >> 23158971 |
Bibiana García-Bailo1, Kaitlin Roke, David M Mutch, Ahmed El-Sohemy, Alaa Badawi.
Abstract
BACKGROUND: Inflammation and oxidative stress are associated with the development of numerous chronic diseases. Circulating ascorbic acid, α-tocopherol, and 25-hydroxyvitamin D (25(OH)D) may help reduce concentrations of pro-inflammatory cytokines through their antioxidant and anti-inflammatory properties. These micronutrients may act synergistically, and they may have different anti-inflammatory effects, but previous studies have assessed the link between each of these micronutrients and inflammation in isolation without controlling for the other micronutrients. Our objective was to examine the association between circulating concentrations of ascorbic acid, α-tocopherol, and 25(OH) D and a panel of pro-inflammatory cytokines in an ethnically diverse population of young adults.Entities:
Year: 2012 PMID: 23158971 PMCID: PMC3515429 DOI: 10.1186/1743-7075-9-102
Source DB: PubMed Journal: Nutr Metab (Lond) ISSN: 1743-7075 Impact factor: 4.169
Study participant characteristics
| | |||
|---|---|---|---|
| Age (years) | 22.7 ± 2.5 | 22.6 ± 2.4 | 0.4363 |
| Ethnicity | |||
| Caucasian | 137 (28.72) | 340 (71.28) | 0.0039 |
| East Asian | 94 (26.86) | 256 (73.14) | |
| South Asian | 48 (44.86) | 59 (55.14) | |
| Other | 21 (28.77) | 52 (71.23) | |
| Hormonal contraceptive use among women | | 221 (31.26) | |
| Body mass index (kg/m2) | 23.6 ± 3.5 | 22.4 ± 3.5 | <0.0001 |
| Waist circumference (cm) | 80.1 ± 8.9 | 71.2 ± 7.6 | <0.0001 |
| Physical Activity (Met-h/wk) | 7.7 ± 3.2 | 7.6 ± 3.0 | 0.5423 |
| Serum ascorbic acid (μmol/L) | 26.9 ± 14.6 | 32.1 ± 18.1 | <0.0001 |
| Plasma α-tocopherol (μmol/L) | 29.4 ± 11.1 | 30.3 ± 12.1 | 0.3859 |
| Plasma 25(OH)D (nmol/L) | 46.8 ± 20.1 | 54.5 ± 26.5 | <0.0001 |
| Glucose (mmol/L) | 4.9 ± 0.4 | 4.7 ± 0.3 | <0.0001 |
| Fasting insulin (pmol/L) | 45 ± 25.5 | 49.2 ± 31.1 | 0.0599 |
| Total cholesterol (mmol/L) | 4.0 ± 0.8 | 4.3 ± 0.8 | <0.0001 |
| HDL cholesterol (mmol/L) | 1.3 ± 0.3 | 1.7 ± 0.4 | <0.0001 |
| LDL cholesterol (mmol/L) | 2.3 ± 0.7 | 2.2 ± 0.6 | 0.4176 |
| IL-1RA (pg/mL) | 320.9 ± 206.9 | 322.8 ± 180.2 | 0.5030 |
| IFN-γ (pg/mL) | 185 ± 132.7 | 201.3 ± 134.7 | 0.0275 |
| IP-10 (pg/mL) | 558.2 ± 290.7 | 613.1 ± 478.4 | 0.3515 |
| PDGF-bb (pg/mL) | 1316.7 ± 2642.2 | 1152.8 ± 1729 | 0.5038 |
| RANTES (pg/mL) | 2378.7 ± 3176.2 | 2465.7 ± 1350.6 | 0.0023 |
1: Shown are crude, untransformed means ± standard deviations or n (%).
†: p-value from χ2 analysis for categorical variables and t-test for continuous variables, using loge- or square-root transformed values as necessary.
Figure 1Crude correlation analysis between circulating vitamin concentrations and cytokines. Shown are Pearson’s (r) coefficients and p values only for significantly correlated variables. Variables were loge- or square root-transformed as necessary prior to analysis. The observed correlations between specific vitamins and cytokines were all weak. By contrast, we observed a greater range in the strength of the correlations between specific cytokines.
Mean cytokine concentrations by vitamin tertiles
| | Serum ascorbic acid | | ||||
| IL-1RA | 310.67 ± 11.46 | 329.51 ± 9.6 | 326.03 ± 9.75 | 0.0624 | 0.0468 | 0.0413 |
| IFN-γ | 179.79 ± 7.33a | 204.95 ± 7.42b | 204.23 ± 7.15b | 0.0006 § | 0.0002 § | 0.0002 § |
| IP-10 | 594.67 ± 27.52 | 604.55 ± 22.24 | 590.56 ± 20.54 | 0.5878 | 0.5341 | 0.558 |
| PDGF-bb | 1220.29 ± 132.69 | 1136.53 ± 84.63 | 1251.47 ± 114.75 | 0.0686 | 0.0788 | 0.0787 |
| RANTES | 2529.99 ± 91.78 | 2490.87 ± 147.66 | 2295.8 ± 83.83 | 0.3554 | 0.4747 | 0.4962 |
| | Plasma α-tocopherol | | ||||
| IL-1RA | 339.87 ± 12.67 | 317.07 ± 9.97 | 309.71 ± 7.54 | 0.0466 | 0.0248 | 0.0247 |
| IFN-γ | 211.83 ± 7.83a | 197.65 ± 8.16b | 179.97 ± 5.67b | 0.0018 | 0.0004 § | 0.0003 § |
| IP-10 | 608.78 ± 22.85 | 586.16 ± 23.07 | 595.28 ± 24.77 | 0.1821 | 0.1423 | 0.143 |
| PDGF-bb | 1390.83 ± 167.45 | 1150.59 ± 85.74 | 1064.07 ± 44.17 | 0.7387 | 0.7313 | 0.7341 |
| RANTES | 2556.83 ± 105.39a | 2524.51 ± 150.75a | 2238.31 ± 65.6b | <0.0001 § | <0.0001 § | <0.0001 § |
| | Plasma 25(OH)D | | ||||
| IL-1RA | 324.23 ± 10.04 | 315.19 ± 10.38 | 327.19 ± 10.45 | 0.5194 | 0.4750 | 0.5239 |
| IFN-γ | 203.68 ± 7.97 | 187.19 ± 6.2 | 198.56 ± 7.69 | 0.2111 | 0.1626 | 0.2214 |
| IP-10 | 593.58 ± 28.78 | 562.99 ± 18.05 | 633.61 ± 22.56 | 0.4381 | 0.4366 | 0.4027 |
| PDGF-bb | 1050.22 ± 81.85 | 1260.6 ± 148.14 | 1293.67 ± 92.93 | 0.9075 | 0.8993 | 0.9023 |
| RANTES | 2174.88 ± 62.99 | 2427.65 ± 167.06 | 2715.98 ± 77.22 | 0.0561 | 0.0523 | 0.0236 |
1)Shown are crude, untransformed means ± standard errors.
†: p-value from ANCOVA with loge- or square-root transformed cytokine and vitamin concentrations where necessary.
Model 1: adjusted for age, sex, ethnicity, waist circumference, physical activity, season, total cholesterol, and hormonal contraceptive use among women.
Model 2: 2)For ascorbic acid, adjusted for the covariates listed in Model 1 plus serum α-tocopherol; 3)For α-tocopherol, adjusted for Model 1 plus ascorbic acid; 4)For 25(OH)D, adjusted for Model 1 plus ascorbic acid.
Model 3: 5)For ascorbic acid, adjusted for Model 2 plus 25(OH)D; 6)For α-tocopherol, adjusted for Model 2 plus 25(OH)D; 7)For 25(OH)D, adjusted for Model 2 plus α-tocopherol.
§: These p-values meet the Bonferroni level of significance for 45 tests (p = 0.0011; α = 0.05; 5 cytokines x 3 vitamins x 3 models).
a,b,c: Superscript letters indicate significant differences in cytokine concentrations between tertiles (p < 0.05), after adjustment for all covariates included in Model 3. The Tukey-Kramer procedure was used to adjust for multiple comparisons between groups within each ANCOVA. These post-hoc comparisons were only performed when Model p-values met the Bonferroni level of significance.